According to the Drug Information Handbook for Dentistry the potential effects on dental treatment while using bisphosphonates is as follows: Osteonecrosis of the jaw (ONJ), generally associated with local infection and/or tooth extraction and often with delayed healing, has been reported in patients taking bisphosphonates (i.e. Fosamax, Boniva, Actonel, Reclast, etc.) Symptoms included non-healing extraction socket or an exposed jawbone. Most reported cases of bisphosphonates-associated osteonecrosis have been in cancer patients treated with intravenous bisphosphonates. However, some have occurred in patients with postmenopausal osteoporosis taking oral bisphosphonates. Dental surgery may exacerbate ONJ. For patients requiring dental procedures, there are no data available to suggest whether discontinuation of bisphosphonates treatment reduces the risk of ONJ. Patients who develop ONJ while on bisphosphonates therapy should receive care by an oral surgeon.